Government investment and a joined-up plan are needed for the UK to become a global leader in regenerative medicine therapies, the House of Lords science and technology committee was told.
As part of the committee’s inquiry into regenerative medicine, peers heard today (20 November) from industry and academic witnesses about the finance and support needed for regenerative medicine in the UK.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.